GGrantIndex
← Search

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY

$0M01FY2000RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

Abstract

The purpose of this study is to determine if therapy with angiotensin converting enzyme (ACE) inhibitor therapy is more beneficial than a placebo (no therapy) in preventing progression of renal insufficiency and eliminating proteinuria in patients with sickle cell nephropathy (a kidney disorder that is caused by Sickle Cell disease).

View original record on NIH RePORTER →